Screener
60 Degrees Pharmaceuticals SXTP Q4 2025 Annual earnings
Reported March 26, 2026 · Before market open
Revenue$300.0KMiss by $20.0K
EPS-$1.91Beat by $0.37
Revenue estimate$320.0K
EPS estimate-$2.28
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$270.0K
EPS estimate-$0.61
Versus estimates
Revenue
Diluted EPS
FAQ
- When did 60 Degrees Pharmaceuticals report Q4 2025 earnings?
- 60 Degrees Pharmaceuticals (SXTP) reported Q4 2025 earnings on March 26, 2026 before market open.
- What were 60 Degrees Pharmaceuticals's Q4 2025 revenue and EPS?
- 60 Degrees Pharmaceuticals reported revenue of $300.0K and eps of $-1.91 for Q4 2025.
- Did 60 Degrees Pharmaceuticals beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $320.0K by $20.0K. EPS beat the consensus estimate of $-2.28 by $0.37.
- How did 60 Degrees Pharmaceuticals's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 14.7% from $261.4K a year earlier and eps grew 86.5% from $-14.20.
- Where can I find 60 Degrees Pharmaceuticals's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001554855-26-000467) directly on SEC EDGAR. The filing index links above go to sec.gov.
